Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Schizophrenia Research
|
December 3, 2013
Comments on the scoring guideline of the personal and social performance scale (PSP)
Mark Opler, Dong-Jing Fu
Expert Opinion on Pharmacotherapy
|
March 3, 2016
Paliperidone for the treatment of schizoaffective disorder
Larry Alphs, Dong-Jing Fu, Ibrahim Turkoz
JAMA Psychiatry
|
November 5, 2025
Esketamine for Treatment-Resistant Depression-Reply
Adam Janik, Richard C Shelton, Dong-Jing Fu
Genomics
|
January 7, 2004
Genotyping with TaqMAMA
Baohui Li, Ibrahim Kadura, Dong-Jing Fu, et al.
Innovations in Clinical Neuroscience
|
May 26, 2016
The Direct and Indirect Effects of Paliperidone Extended-release on Depressive Symptoms in Schizoaffective Disorder: A Path Analysis
Ibrahim Turkoz, Dong-Jing Fu, Cynthia A Bossie, et al.
Neuropsychiatric Disease and Treatment
|
October 20, 2010
Role of paliperidone extended-release in treatment of schizoaffective disorder
Carla M Canuso, Ibrahim Turkoz, Dong Jing Fu, et al.
Innovations in Clinical Neuroscience
|
September 18, 2012
Comparison of the peak-to-trough fluctuation in plasma concentration of long-acting injectable antipsychotics and their oral equivalents
John J Sheehan, Kristin R Reilly, Dong-Jing Fu, et al.
Journal of Affective Disorders
|
January 24, 2016
Rapid onset of treatment effects on psychosis, depression, and mania in patients with acute exacerbation of schizoaffective disorder following treatment with oral extended-release paliperidone
Dong-Jing Fu, Ibrahim Turkoz, Cynthia A Bossie, et al.
The Journal of Nervous and Mental Disease
|
December 23, 2016
Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder
Cynthia A Bossie, Ibrahim Turkoz, Larry Alphs, et al.
Journal of Clinical Psychopharmacology
|
August 16, 2016
Treatment Patterns and Antipsychotic Medication Adherence Among Commercially Insured Patients With Schizoaffective Disorder in the United States
Kruti Joshi, Jay Lin, Melissa Lingohr-Smith, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Schizophrenia Research
|
December 3, 2013
Comments on the scoring guideline of the personal and social performance scale (PSP)
Mark Opler, Dong-Jing Fu
Expert Opinion on Pharmacotherapy
|
March 3, 2016
Paliperidone for the treatment of schizoaffective disorder
Larry Alphs, Dong-Jing Fu, Ibrahim Turkoz
JAMA Psychiatry
|
November 5, 2025
Esketamine for Treatment-Resistant Depression-Reply
Adam Janik, Richard C Shelton, Dong-Jing Fu
Genomics
|
January 7, 2004
Genotyping with TaqMAMA
Baohui Li, Ibrahim Kadura, Dong-Jing Fu, et al.
Innovations in Clinical Neuroscience
|
May 26, 2016
The Direct and Indirect Effects of Paliperidone Extended-release on Depressive Symptoms in Schizoaffective Disorder: A Path Analysis
Ibrahim Turkoz, Dong-Jing Fu, Cynthia A Bossie, et al.
Neuropsychiatric Disease and Treatment
|
October 20, 2010
Role of paliperidone extended-release in treatment of schizoaffective disorder
Carla M Canuso, Ibrahim Turkoz, Dong Jing Fu, et al.
Innovations in Clinical Neuroscience
|
September 18, 2012
Comparison of the peak-to-trough fluctuation in plasma concentration of long-acting injectable antipsychotics and their oral equivalents
John J Sheehan, Kristin R Reilly, Dong-Jing Fu, et al.
Journal of Affective Disorders
|
January 24, 2016
Rapid onset of treatment effects on psychosis, depression, and mania in patients with acute exacerbation of schizoaffective disorder following treatment with oral extended-release paliperidone
Dong-Jing Fu, Ibrahim Turkoz, Cynthia A Bossie, et al.
The Journal of Nervous and Mental Disease
|
December 23, 2016
Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder
Cynthia A Bossie, Ibrahim Turkoz, Larry Alphs, et al.
Journal of Clinical Psychopharmacology
|
August 16, 2016
Treatment Patterns and Antipsychotic Medication Adherence Among Commercially Insured Patients With Schizoaffective Disorder in the United States
Kruti Joshi, Jay Lin, Melissa Lingohr-Smith, et al.
Page
of 8